Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
| NCT ID | NCT04949113 |
| Title | Neoadjuvant Ipilimumab Plus Nivolumab Versus Standard Adjuvant Nivolumab in Macroscopic Stage III Melanoma (NADINA) |
| Acronym | NADINA |
| Recruitment | Active, not recruiting |
| Gender | |
| Phase | Phase III |
| Variant Requirements | No |
| Sponsors | The Netherlands Cancer Institute |
| Indications | |
| Therapies | |
| Age Groups: | adult | child | senior |
| Covered Countries | USA | NLD | AUS |